País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Diphenhydramine hydrochloride; Levomenthol
McNeil Products Ltd
R06AA52
Diphenhydramine hydrochloride; Levomenthol
2.8mg/1ml ; 400microgram/1ml
Oral solution
Oral
No Controlled Drug Status
Invalid to prescribe in NHS primary care
BNF: 03090200; GTIN: 5010123639037 5010123731465
IF YOU ARE PREGNANT OR BREAST-FEEDING ■ Ask your doctor or pharmacist for advice before taking this medicine if you are pregnant or breast-feeding. SPECIAL WARNINGS ABOUT THIS MEDICINE ■ This medicine may cause drowsiness. If affected, do not drive or operate machinery. Avoid alcoholic drink. SOME OF THE INGREDIENTS CAN CAUSE PROBLEMS ■ This medicine contains sucrose and liquid glucose. If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicinal product. Contains 3.5 g glucose per 5 ml. This should be taken into account in patients with diabetes mellitus. ■ This medicinal product contains 5 vol % ethanol (alcohol), i.e. up to 200 mg per dose, equivalent to 5 ml beer, 2 ml wine per 5 ml. Harmful for those suffering from alcoholism. To be taken into account in pregnant or breast-feeding women, children and high-risk groups such as patients with liver disease or epilepsy. ■ Ponceau 4R (E124) may cause allergic reactions. ■ This medicinal product contains 16.61 mg sodium per 5 ml. To be taken in consideration by patients on a controlled sodium diet. 3 HOW TO TAKE THIS MEDICINE CHECK THE TABLE THAT FOLLOWS TO SEE HOW MUCH MEDICINE TO TAKE. ■ For oral use only. ■ Do not take more than the stated dose shown. 2 BEFORE TAKING THIS MEDICINE This medicine is suitable for most people but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist. DO NOT USE THIS MEDICINE… ■ If you have ever had a BAD REACTION to any of the ingredients. ■ If you have had a COUGH for a few weeks that may be caused by ASTHMA, or a cough which brings up a lot of mucus (phlegm). ■ If you are taking, or have taken in the last two weeks, DRUGS FOR DEPRESSION known as Monoamine Oxidase Inhibitors (MAOIs). ■ For children under 12 years old. If any of these apply to you, GET ADVICE FROM A DOCTOR OR PHARMACIST WITHOUT USING BENYLIN CHESTY COUGHS ORIGINAL. TALK TO YOUR DOCTOR OR PHARMACIST… ■ If you suffer from LIVER or KID Leia o documento completo
OBJECT 1 BENYLIN CHESTY COUGHS (ORIGINAL) Summary of Product Characteristics Updated 08-Aug-2014 | McNeil Products Ltd 1. Name of the medicinal product Benylin Chesty Coughs (Original) 2. Qualitative and quantitative composition Each 5 ml contains:- Diphenhydramine hydrochloride 14.0 mg L-menthol 2.0 mg 3. Pharmaceutical form Syrup. A clear red syrup 4. Clinical particulars 4.1 Therapeutic indications BENYLIN CHESTY COUGHS (ORIGINAL) is indicated for the relief of cough and associated congestive symptoms. 4.2 Posology and method of administration For oral use ADULTS AND CHILDREN AGED 12 YEARS AND OVER: One 10 ml dose of syrup 4 times a day. Maximum daily dose: 40 ml syrup. CHILDREN UNDER 12 YEARS: Benylin Chesty Coughs (Original) is contraindicated in children under the age of 12 years (see section 4.3). THE ELDERLY: As for adults above (see Pharmacokinetics - The elderly). Hepatic dysfunction Caution should be exercised if moderate to severe hepatic dysfunction is present (see Pharmacokinetics - Hepatic dysfunction). Renal dysfunction It may be prudent to increase the dosage interval in subjects with moderate to severe renal failure (see Pharmacokinetics - Renal dysfunction). Do not exceed the stated dose. Keep out of the reach and sight of children. 4.3 Contraindications BENYLIN CHESTY COUGHS (ORIGINAL) is contraindicated in individuals with known hypersensitivity to the product or any of its constituents. Benylin Chesty Coughs (Original) is contraindicated in individuals with chronic or persistent cough, such as occurs with asthma, or where cough is accompanied by excessive secretions, unless directed by the physician. Benylin Chesty Coughs (Original) should not be administered to patients currently receiving monoamine oxidase inhibitors (MAOI) or those patients who have received treatment with MAOIs within the last two weeks. Not to be used in children under the age of 12 years. 4.4 Special warnings and precautions for use This product may cause drowsiness. If affected individuals should not drive or operate Leia o documento completo